Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_2
1
25%
Ph phase_1
1
25%
Ph phase_4
1
25%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Not yet recruiting1
Terminated1
Completed1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

not_yet_recruiting125%
terminated125%
completed125%
enrolling_by_invitation125%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_4

Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia

NCT04948463
not_yet_recruitingphase_2

Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial

NCT07485010
enrolling_by_invitationphase_1

Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection

NCT07228702
terminatednot_applicable

Raja Isteri Pengiran Anak Saleha Appendicitis Treatment Without Operation

NCT03169114

Clinical Trials (4)

Showing 4 of 4 trials
NCT04948463Phase 4

Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia

Completed
NCT07485010Phase 2

Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial

Not Yet Recruiting
NCT07228702Phase 1

Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection

Enrolling By Invitation
NCT03169114Not Applicable

Raja Isteri Pengiran Anak Saleha Appendicitis Treatment Without Operation

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4